A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing

Ben Mulhearn, Danyang Li, Fionnuala McMorrow, Hui Lu, Neil J. McHugh, Sarah L. Tansley

Research output: Contribution to journal › Article › peer-review

6 Citations (SciVal)
5 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing'. Together they form a unique fingerprint.

Medicine & Life Sciences